AMLODIPINFORMULIERUNGEN

Patent europeic · EP3960158 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3960158
Numer da la dumonda
EP21190149
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
06-10-2017
Publitgà
02-03-2022
Concedì
21-05-2025
Stritgà
27-05-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/10 (2006.01)
A61K 47/02 (2006.01)
A61K 47/12 (2006.01)
A61K 47/26 (2006.01)
A61K 47/34 (2017.01)
A61K 47/38 (2006.01)
A61P 9/12 (2006.01)
A61K 31/4422 (2006.01)
Prioritad
US 201662405455 P 07.10.2016
Derivà da
EP17859269
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 27-05-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    27.05.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 27.05.2026

  2. 02-04-2026

    Midada

    Published in Swissreg on 02.04.2026

  3. 21-05-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.05.2025

Partidas

Possessur

Silvergate Pharmaceuticals, Inc.

6251 Greenwood Plaza Blvd. Suite 101, Greenwood Village, CO 80111, US

Inventur

BRAUER, Scott

Harrisonville, MO 64701, US

MOSHER, Gerold L

Kansas City, MO 64145, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.